Disease/Infection News

RSS

Saint Louis University to participate in PPV23 vaccine trial for pneumonia

Saint Louis University is participating in a multi-site, National Institutes of Health-sponsored clinical trial in older adults of a new vaccine designed to protect against one of the most common types of pneumonia and related diseases such as bloodstream infections and meningitis.

16 Oct 2012

Saint Raphael Campus of Yale New Haven Hospital honored for achievements in eliminating HAIs

The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).

16 Oct 2012

Physicians urged to think twice before they prescribe compounded drugs

The recent outbreak of meningitis in the US-and the subsequent deaths of 15 individuals-has renewed scrutiny on the contemporary practice of pharmacy compounding. The risks to patients, and associated liability risk to prescribing physicians, largely outweigh the benefits when the practice goes beyond the traditional, extemporaneous role, according to Sarah Sellers from q-Vigilance LLC and Wulf Utian from Case Western Reserve University in the US. Sellers and Utian's opinion piece appears online in the journal Drugs, published by Adis.

16 Oct 2012

UPC improves antimicrobial properties of medical textiles

The Molecular and Industrial Biotechnology Group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) has improved the antimicrobial properties of medical textiles using an enzymatic pre-treatment combined with simultaneous deposition of nanoparticles and biopolymers under ultrasonic irradiation.

16 Oct 2012

International cooperation essential to help Uganda fight malaria

Uganda "has overcome a violent past, but hope is daily threatened by a force more deadly than any warlord or civil unrest": the mosquito, Ugandan Health Minister Christine Ondoa writes in a GlobalPost opinion piece. According to the WHO, "Uganda has the highest incidence of malaria in the world," and the disease is endemic in more than 95 percent of the country, she notes.

15 Oct 2012

U.S. can draw lessons from PEPFAR success to address epidemic in black America

"Thirty years ago, the CDC reported the first cases of HIV/AIDS in New York and Los Angeles," Foreign Policy In Focus columnist Kwei Quartey writes in the Huffington Post World Blog, noting, "Since the beginning of the epidemic, over 600,000 people have died of AIDS in the United States, and 1.2 million people are currently living with HIV."

15 Oct 2012

Merck, AiCuris enter licensing agreement for novel HCMV candidates

Merck, known as MSD outside the United States and Canada, and AiCuris today announced that they have entered into an exclusive worldwide licensing agreement for AiCuris' novel portfolio of investigational medicines targeting Human Cytomegalovirus (HCMV), including letermovir (AIC246), an oral, late-stage antiviral candidate being investigated for the treatment and prevention of HCMV infection in transplant recipients.

15 Oct 2012

Researchers develop two ultra-rapid tests for diagnosis of antibiotic resistance

With their excellent sensitivity and specificity, the use of these extremely efficient tests on a world-wide scale would allow us to adapt antibiotic treatments to the individual's needs and to be more successful in controlling antibiotic resistance, particularly in hospitals.

15 Oct 2012

Researchers identify keys and doors of Anaplasmataceae tick-borne bacterium

Virginia Commonwealth University School of Medicine researchers have identified the "keys" and "doors" of a bacterium responsible for a series of tick-transmitted diseases. These findings may point researchers toward the development of a single vaccine that protects against members of an entire family of bacteria that cause disease in humans, domestic animals and livestock.

15 Oct 2012

Indonesia issues order to override patents on 7 HIV, hepatitis drugs

"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."

15 Oct 2012

GlaxoSmithKline to make clinical trial data available to other researchers

GlaxoSmithKline (GSK) CEO Andrew Witty "said on Thursday detailed data from its clinical trials would be made available to other researchers," Reuters reports, adding, "That would include anonymized patient-level results that sit behind clinical trials of approved and failed drugs."

15 Oct 2012

PEPFAR launches training initiative for HIV/AIDS organizations in Bahamas

"On Wednesday, October 10, U.S. and Bahamian officials attended the official launch of 'The Caribbean Grant Solicitation and Management Program,' a new PEPFAR initiative that will be executed locally by the U.S.-based nonprofit World Learning through USAID," a press release from the U.S. Embassy in Nassau, Bahamas, reports.

15 Oct 2012

S. African National AIDS Council CEO speaks to PlusNews about reform, funding

Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.

15 Oct 2012

Tanzania investigating circulation of fake HIV drugs, stops local ARV production

BBC News reports on an investigation into the circulation of fake HIV drugs in Tanzania, writing, "Analysts say there is concern about the quality of locally made drugs given widespread corruption in political circles in the East Africa nation."

15 Oct 2012

Gardasil does not increase sexual activity in girls

The human papillomavirus (HPV) vaccine known as Gardasil is not associated with an increase in pregnancy, sexually transmitted infections, or contraceptive counseling, according to a Kaiser Permanente study published online today in the journal Pediatrics.

15 Oct 2012

Global Fund, Churches Health Association of Zambia sign grant agreement worth $102M

"The Global Fund to Fight AIDS, Tuberculosis and Malaria signed a grant agreement worth $102 million with the Churches Health Association of Zambia [CHAZ] Wednesday," Devex's "Development Newswire" reports.

13 Oct 2012

Mexican government, NGOs working to expand access to clean syringes to prevent HIV among IDUs

Inter Press Service examines how Mexico's government and non-governmental organizations are working to stem the spread of HIV among people who use injection drugs. "According to a project financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria since 2011, the prevalence of HIV/AIDS in Mexico is 5.77 percent among intravenous drug users ... compared to 0.24 to 0.3 percent in the general population aged 15 to 49," IPS writes, noting HIV prevalence among drug users is highest in "northern Mexico, one of the areas in the country hit hardest by drug trafficking."

13 Oct 2012

Financial Times features special report on NTDs

The Financial Times has published a special report on neglected tropical diseases (NTDs) featuring 10 articles examining issues including prevention, research, and treatment.

12 Oct 2012

UNAIDS to support Republic of Congo's efforts to reduce HIV MTCT

UNAIDS Executive Director Michel Sidibe "on Wednesday hailed the efforts of the Republic of Congo government in the fight against HIV/AIDS in general, and particularly in the reduction of transmission from mother to child," Xinhua reports.

12 Oct 2012

Bureaucracy in India slowing treatment of TB, Wall Street Journal reports

The Wall Street Journal examines how bureaucracy in India is slowing the treatment of tuberculosis (TB) in the country. The newspaper recounts the story of Rahima Sheikh, "one of 16 patients identified by Mumbai doctors to be resistant to virtually all traditional TB treatments."

12 Oct 2012